openPR Logo
Press release

Global Albumin Market Assessment 2017-2021

05-16-2017 02:11 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: SA-BRC

Human albumin is the most abundant protein present in the blood and comprises almost half of serum protein. The protein is produced in the liver and is responsible for carrying a number of substances through the body such as hormones, cholesterol, fatty acids and bilirubin among others. Albumin is a unique constituent that balances blood volume, can act both as a therapeutic agent for restoration and maintenance of circulating blood volume and to carry therapeutic agents such as pharmaceutical drugs where it acts as an excipient. Albumin is used for treatment of blood loss shock in cases of excessive bleeding, hypoalbuminemia, surgery or burns.

There are three types of albumins used for therapeutics and health that are currently being analyzed for this report by SA-BRC; Bovine & Fetal Bovine Serum (BSA), Recombinant Human Albumin (rHA) and Human Serum Albumin (HSA). The market for albumin is driven by the overall demand from plasma derived proteins, demand from pharmaceutical industry for albumin as an excipient, and as a therapeutic agent in hospitals. Advantages of using HSA as a carrier include are that the substance is native to the body, biodegradable, non-toxic and non-immunogenic, stability over a wide PH range and versatility in binding with different agents. The demand BSA continues to grow steadily stemming from growth of immunodiagnostics, clinical chemistry reagents, cell culture media, protein research, and molecular biology laboratories. Along with BSA, there is also a rising demand for serum albumin from other animal sources such as horses and pigs that is regularly used for research purpose.

Request Free Report Sample@ www.sa-brc.com/Global-Albumin-Market-Assessment--Forecast...

The report covers the market for these three types of albumin across applications such as drug formulation, drug delivery, vaccines, health& wellness and culture media. The analysis will encompass the market for six geographies of North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. China is anticipated to be one of the largest markets that imports albumin as the only plasma derived pharmaceutical accounting for 50% of the total plasma-based pharmaceuticals market. Albumin is now being used for unique drug delivery techniques such as microspheres and nanoparticles to deliver NSAIDS and other drugs for oncology.

Key players in this market include Grifols, CSL Behring, Kamada, Sigma Aldrich, Invitria, Albumedix, Merck Millipore, Kaketsuken among several others in a fragmented market. The rHA market is anticipated to grow with the quickest pace in through the forecast period with greatest demand rising from pharmaceutical industry.

Request For TOC@ www.sa-brc.com/Global-Albumin-Market-Assessment--Forecast...

NOTE: This report is currently under research and will be made available to clients on request.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
Office No. 14,
Hermes Kunj, Mangaldas Road,
Pune, 411001
India
Phone: +91-02041210872
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Albumin Market Assessment 2017-2021 here

News-ID: 538437 • Views: 471

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases


More Releases for Albumin

Global Serum Albumin Market Research Report
This report studies the global Serum Albumin market status and forecast, categorizes the global Serum Albumin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Octapharma Kedrion CSL Behring Shire (Baxter) Grifols Hualan Bio Taibang Bio RAAS Greencross Geographically, this report studies
Global Glycated Albumin Market Growth 2019-2024
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy. Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Albumin Market, Growing $10,305 Million By 2023
Albumin is globular protein found in blood plasma. Serum albumin is the most abundant plasma protein, constituting around 50% of human plasma protein. Albumin is obtained from plasma fractionation process where human serum albumin and bovine serum albumin is most widely used. Recombinant albumin is produced using recombinant techniques in rice plants, yeast species, and other cell lines. Albumin is used as blood volumizer and is employed in the treatment
Global Albumin Market $307 Million by 2021
According to a market research report Albumin Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global albumin market is estimated to reach $307 Million in 2021, expanding at a CAGR of 2.4% from 2017 to 2021. The global albumin market segmentation is based on type (human serum albumin, bovine serum albumin, recombinant albumin), and its applications (drug formulation and drug delivery, vaccines, components of media). The global albumin market
Global Glycated Albumin Sales Market Report 2017
24 Market Reports provides a complete data analysis of Global Glycated Albumin Sales Market Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the global Glycated Albumin market is expected to reach high by the end of 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated